---
title: Joel Kahn, MD, on the New Focus for Vascular Protection
description: Dr. Kahn describes how he came to recognize the importance of the endothelial glycocalyx in preventing cardiovascular disease.
image: https://blog.calroy.com/hubfs/Dr%20Joel%20Kahn.jpg
---
Calroy Health Sciences | 1-800-609-6409
[ ](https://arterosil.com/)
- [** ](https://arterosil.com/my-account)
- [** ](https://blog.calroy.com/importance-glycocalyx-prevention#)
-
## Arterosil by Calroy Health Sciences Blog
# Joel Kahn, MD, on the New Focus for Vascular Protection
Posted by [Calroy Health Sciences](https://blog.calroy.com/author/calroy-health-sciences) on Dec 10, 2020 12:31:57 PM
[](https://blog.calroy.com/importance-glycocalyx-prevention#playvideo)
## **"The endothelial glycocalyx is a very hot topic."**
For many years, Dr. Kahn had a thriving practice in aggressive interventional cardiology, and he combined dietary advice with surgical work even early in his career. Eventually, as he continued to review the mounting research on lifestyle factors, he decided to focus his practice on the prevention of cardiometabolic issues. Dr. Kahn’s science-based protocol combines a whole-food plant-based diet, regular exercise, smoking avoidance, and healthy loving relationships.
In this brief video excerpt, Dr. Kahn describes how he came to recognize the importance of the endothelial glycocalyx (EGX) in the early prevention of cardiovascular disease:
* Joel Kahn, MD, FACC, directs the Kahn Center for Cardiac Longevity and serves as Clinical Professor of Medicine/Cardiology at the Wayne State University School of Medicine. *
The EGX is a micro-thin, gel-like that provides a selectively permeable barrier to the entire endothelium. It was only discovered when technological advances enabled its visualization and is still largely unknown outside the scientific community.
In focusing on the EGX as the key to endothelial health, Dr. Kahn is drawing on a surge of scientific research in recent years, which has uncovered the multiple roles of this important structure.
Among other functions, the EGX:1
- Limits LDL access to the endothelium
- Inhibits platelet adherence
- Prevents leukocyte adherence
- Triggers shear-induced nitric oxide
- Harbors coagulation regulatory factors
- Houses extracellular superoxide dismutase
- Modulates inflammatory responses
- Buffers blood sodium
In Dr. Kahn’s words:
Dr. Joel Kahn has grown an enthusiastic following among medical practitioners and the general public through his consistent promotion of lifestyle solutions to cardiovascular problems.
To learn more about the physiology of the endothelial glycocalyx, watch a short presentation by Kristine Burke, MD.
[](https://cta-redirect.hubspot.com/cta/redirect/7072026/7da97c23-3135-43f5-8a2a-b2f947ba0133)
### Reference
1. Reitsma, Sietze, et al. “The Endothelial Glycocalyx: Composition, Functions, and Visualization.” *Pflugers Archiv,* vol. 454, no. 3, June 2007, pp. 345–59, doi:[10.1007/s00424-007-0212-8](https://doi.org/10.1007/s00424-007-0212-8)
**IMPORTANT NOTICE:
The information on this webpage is for licensed healthcare practitioner education only, and is not to be disseminated to the general public.**
Topics: [Joel Kahn, MD, FACC](https://blog.calroy.com/tag/joel-kahn-md-facc)
## Arterosil Research Summary
### **[Free Download](https://arterosil.com/research/) **
Numerous cellular, animal and human studies have been conducted to evaluate the biological activities, mode of mechanisms, and therapeutic benefits of Arterosil, a patent-pending nutraceutical. Studies include:
- MRI Carotid Plaque Regression Study
- Glycocalyx Regeneration Study
- Leukocyte Adhesion Study
- Arterial Elasticity Study
- Hypertension Study
Download Arterosil's Research Summary [here](https://arterosil.com/research/).
### Subscribe Here!
### Recent Posts
### Posts by Tag
- [Kristine Burke, MD (4)](https://blog.calroy.com/tag/kristine-burke-md)
- [Joel Kahn, MD, FACC (3)](https://blog.calroy.com/tag/joel-kahn-md-facc)
- [Samuel Yanuck, DC (3)](https://blog.calroy.com/tag/samuel-yanuck-dc)
- [Endothelial glycocalyx (2)](https://blog.calroy.com/tag/endothelial-glycocalyx)
- [Jack Wolfson, DO, FACC (2)](https://blog.calroy.com/tag/jack-wolfson-do-facc)
- [Mark Houston, MD (2)](https://blog.calroy.com/tag/mark-houston-md)
- [Vascular Health (2)](https://blog.calroy.com/tag/vascular-health)
- [AASCP (1)](https://blog.calroy.com/tag/aascp)
- [George Stokes, MD (1)](https://blog.calroy.com/tag/george-stokes-md)
- [Kara Fitzgerald, ND (1)](https://blog.calroy.com/tag/kara-fitzgerald-nd)
- [Mark Hyman, MD (1)](https://blog.calroy.com/tag/mark-hyman-md)
- [Robert Sheeler, MD (1)](https://blog.calroy.com/tag/robert-sheeler-md)
- [Sunny Kim, MD (1)](https://blog.calroy.com/tag/sunny-kim-md)
[See all](https://blog.calroy.com/importance-glycocalyx-prevention#)
** **These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.* **
**U.S. Patent No. 11,135,238. International Patents Pending.**
© 2022 Calroy Health Sciences. All rights reserved.
- [ ](https://arterosil.com)
- [ ](http://calroy.com/)
**Calroy Health Sciences, LLC**
14362 N Frank Lloyd Wright, Suite 1000
Scottsdale, AZ 85260
1-800-609-6409
1-480-454-5566 (fax)
7325 W Friendly Ave, Ste H
Greensboro, NC 27410
1-800-609-6409
1-480-454-5566 (fax)